Evidence of Effectiveness: Combining Twelve Step Treatment with Medications for Opioid Use Disorder

Wednesday, March 18 | noon-1 p.m. Central

Learn about the feasibility and effectiveness of administering medication-assisted treatment for opioid use disorder (OUD) within a Twelve Step treatment program. Hazelden Betty Ford’s chief medical officer, Marvin D. Seppala, MD, will describe the treatment center’s evidence-based protocols targeting OUD and discuss results of a six-month outcomes study showing dramatic improvements in treatment retention, engagement and continuous abstinence rates.

Objectives

• Describe the primary evidence-based practices used in treatment of OUD

• Recognize the hurdles Twelve Step-based programs face when adding medications to treat OUD

• Apply outcome study results to support the combination of medications with Twelve Step-based treatment

A certificate of completion will be awarded for attending.

Can’t join us March 18?

Register and you will receive notice when we post the recording for on-demand viewing.

About the Presenter

A psychiatrist, author and thought leader in the addiction treatment and recovery field, Marvin D. Seppala, MD, serves as chief medical officer of the Hazelden Betty Ford Foundation where he led development of a pioneering treatment protocol targeting opioid use disorder, Comprehensive Opioid Response with the Twelve Steps (COR-12®).

Questions? Please contact Ann Tucker.